James J. Peters Veterans Affairs Medical Center
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, James J. Peters Veterans Affairs Medical Center sits in the top decile of US sponsors by registered trial count (#442 of 15,742 sponsors by registered trial count).
James J. Peters Veterans Affairs Medical Center: 39 sponsored US clinical trials, 4 recruiting.
James J. Peters Veterans Affairs Medical Center sponsors 39 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 32 completed. 10 of these trials are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Spinal Cord Injury, with 5 trials.
Top-decile sponsor footprint
James J. Peters Veterans Affairs Medical Center ranks in the top decile of sponsors by registered trial count (#442 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
32 of 33 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (97.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
39 total, page 1 of 1
Psilocybin to Treat Depression in Spinal Cord Injury
NCT07251491
Autonomic Effects of Spinal Cord Stimulation in Spinal Cord Injury
NCT05960448
Treatment of Orthostatic Hypotension in SCI
NCT05839652
Seated Balance Using the Indego™
NCT04047992
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI
NCT05101018
Neostigmine and Glycopyrrolate by Iontophoresis
NCT06351995
Transdermal Administration by a Novel Wireless Iontophoresis Device
NCT06351852
Pharmacokinetics of Neostigmine and Glycopyrrolate
NCT04027972
Once Weekly GLP-1 in Persons With Spinal Cord Injury
NCT03292315
RAAS and Arterial Stiffness in SCI
NCT04510974
Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury
NCT03602014
Use of a Prokinetic Agent as an Adjunct to Thrice Weekly Bowel Care After SCI
NCT04671030
Transdermal Iontophoresis of Vitamin B12 Under Three Different Skin Preparations
NCT04027959
Treatment of Post-SCI Hypotension
NCT02919917
Treating Cognitive Deficits in Spinal Cord Injury
NCT03037879
The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury
NCT03029442
Subcutaneous Injection and Ultrasonic Dispersion of Cefazolin Into Chronic Pelvic-Region Pressure Ulcers in Persons With Spinal Cord Injury
NCT02584426
A Longitudinal Examination of Aging With a Spinal Cord Injury: Cardiovascular, Cerebrovascular and Cognitive Consequences
NCT03023163
The Effects of Normalizing Blood Pressure on Cerebral Blood Flow in Hypotensive Individuals With Spinal Cord Injury
NCT02893553
Thermoregulation and Cognition During Cool Ambient Exposure in Tetraplegia
NCT02379156
Exoskeletal-assisted Walking to Improve Mobility, Bowel Function and Cardio-Metabolic Profiles in Persons With SCI
NCT02314221
24hr Effects of Tiotropium Bromide in Tetraplegia
NCT02586649
Blood Pressure, Cerebral Blood Flow and Cognition in Spinal Cord Injury
NCT02307565
Home/Work, Community Mobility Skills in the ReWalk Exoskeleton in Persons With SCI
NCT02118194
Coronary Artery Calcification Score and Risk Factors for Coronary Artery Disease in Persons With Spinal Cord Injury
NCT02007226
Impact of Age on Cardiovascular, Cerebrovascular and Cognitive Health in Spinal Cord Injury
NCT01984476
Cardiovascular, Cerebrovascular, and Cognitive Function in Spinal Cord Injury
NCT02122991
Body Temperature in Persons With Tetraplegia When Exposed to Heat
NCT01890915
Transdermal Administration of a Prokinetic Agent for Bowel Evacuation in Persons With SCI
NCT02370862
IR and Microvascular Blood Flow in SCI
NCT02034331
Measurement of Autonomic Cardiovascular Integrity in Persons With SCI
NCT01758692
Vitamin D Deficiency and Replacement on Pulmonary and Endocrine Function in SCI
NCT02099955
Body Temperature in Persons With Tetraplegia When Exposed to Cold
NCT01822535
The ReWalk Exoskeletal Walking System for Persons With Paraplegia
NCT01454570
Acetylcholinesterase Inhibition and Orthostatic Hypotension in SCI
NCT02307526
Orthostatic Hypotension Among Veterans
NCT02123303
Exhaled Breath Condensate Biomarkers of Inflammation in Individuals With Chronic Cervical Spinal Cord Injury
NCT02235714
A Dose Response Trial Using 5 and 10 Mg of Midodrine Hydrochloride
NCT00426842
Zoledronic Acid Administration in Acute Spinal Cord Injury
NCT02042872
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 5 |
| Phase 3 | 2 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the James J. Peters Veterans Affairs Medical Center pipeline
4 recruiting of 39 indexed (10% open); 32 completed (82%).
Phase mix: 10 late (III/IV) vs 11 early (I/II) (balanced across stages).
Top condition: Spinal Cord Injury (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
James J. Peters Veterans Affairs Medical Center: open-pipeline peers nationwide
Peers matched on 39 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
James J. Peters Veterans Affairs Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 39 trials (± recruiting share)
- Ethicon Endo-Surgery · 39 trials · 3% recruiting
- Maimonides Medical Center · 39 trials · 15% recruiting
- Northeastern University · 39 trials · 38% recruiting
- The Cooper Health System · 39 trials · 23% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Mirati Therapeutics · 10% recruiting · 49 trials
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 10% recruiting · 490 trials
- California Pacific Medical Center Research Institute · 10% recruiting · 29 trials
- National Institute of Environmental Health Sciences (NIEHS) · 10% recruiting · 145 trials
Related
What to do with this James J. Peters Veterans Affairs Medical Center page
39 registered trials is a research-attention snapshot, not an endorsement of James J. Peters Veterans Affairs Medical Center or any single study.
- 4 of James J. Peters Veterans Affairs Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Spinal Cord Injury is the condition James J. Peters Veterans Affairs Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Spinal Cord Injury trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
James J. Peters Veterans Affairs Medical Center pipeline card: 39 registered trials from official public datasets.Report a data error.